BridgeBio Pharma (BBIO) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.95
-0.86
-0.77
-0.68

Details

Expected EPS
-0.678767
Actual EPS
-0.84
Surprise EPS
-0.16
Surprise Percent
+23.75%

Description

BridgeBio Pharma (BBIO) has reported earnings of -0.84 per share for Q2 2026.

0 Comments

Share your thoughts